Valentina Mikhailovna Kudrinskaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Valentina Mikhailovna Kudrinskaya has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Daria Alexeevna Obukhova
Department of Physiology (Pavlov's), Institute of Experimental Medicine, St. Petersburg, Russia; Institute of Human Brain, N.P. Bekhtereva RAS, St. Petersburg, Russia
4 shared publications - Marina Nikolaevna Karpenko
Institute of Experimental Medicine, 197376 Saint Petersburg, Russia
3 shared publications - Tatiana Valentinovna Tiutiunnik
Department of Physiology (Pavlov’s), Institute of Experimental Medicine, Saint Petersburg, Russia
3 shared publications - Viktoriya Aleksandrovna Maystrenko
Institute of Experimental Medicine, St. Petersburg, Russia
3 shared publications - Irina Sergeevna Ivleva
Department of Physiology (Pavlov’s), Institute of Experimental Medicine, St. Petersburg, Russia
2 shared publications - Nina S. Pestereva
Institute of Experimental Medicine
2 shared publications
Latest Publications
- 6 January 2026
- Published by Wiley in Journal of Neuroscience Research
- Vol. 104 (1) , e70106
Tryptophan Hydroxylase: A Target for the Correction of Affective and Neurodegenerative Disorders
Tryptophan hydroxylase (TPH) is a key enzyme in the biosynthesis of serotonin, a neurotransmitter involved in the regulation of mood, emotional state, sleep, appetite, digestion, and cognitive functions. It plays a key role in the creation of a sense of well‐being, reduction of anxiety and control of the response to stress. Imbalances in its levels are associated with many disorders, notably depression, anxiety disorders and migraines. This review examines the structural and functional aspects of the regulation of TPH activity with an emphasis on its isoforms, TPH1 and TPH2, which are responsible for serotonin synthesis in peripheral tissues and in neurons, respectively. Approaches to TPH regulation at the gene, protein, and enzymatic activity levels are discussed. The role of TPH in the pathogenesis of affective disorders such as depression, anxiety, attention deficit hyperactivity disorder and posttraumatic stress disorder is also discussed. Approaches to modulating TPH activity are proposed, including, for example, using calpain inhibitors.
- 6 January 2026
- Published by Wiley in Journal of Neuroscience Research
- Vol. 104 (1) , e70106
Tryptophan Hydroxylase: A Target for the Correction of Affective and Neurodegenerative Disorders
Tryptophan hydroxylase (TPH) is a key enzyme in the biosynthesis of serotonin, a neurotransmitter involved in the regulation of mood, emotional state, sleep, appetite, digestion, and cognitive functions. It plays a key role in the creation of a sense of well‐being, reduction of anxiety and control of the response to stress. Imbalances in its levels are associated with many disorders, notably depression, anxiety disorders and migraines. This review examines the structural and functional aspects of the regulation of TPH activity with an emphasis on its isoforms, TPH1 and TPH2, which are responsible for serotonin synthesis in peripheral tissues and in neurons, respectively. Approaches to TPH regulation at the gene, protein, and enzymatic activity levels are discussed. The role of TPH in the pathogenesis of affective disorders such as depression, anxiety, attention deficit hyperactivity disorder and posttraumatic stress disorder is also discussed. Approaches to modulating TPH activity are proposed, including, for example, using calpain inhibitors.
- 25 May 2025
- Published by Wiley in European Journal of Neuroscience
- Vol. 61 (10) , e70146
Intraperitoneal Single Injection of Dexamethasone Leads to Region‐Specific Changes in the Profile of Neuron‐Specific Proteins in the Rat Brain
This study aims to investigate the effect of dexamethasone (DEX) injection on the production of growth‐associated protein 43 (GAP‐43), the protein that promotes calpain‐2 activation. Increased levels of GAP‐43 in the central nervous system can stimulate plastic and regenerative processes in the brain, which can be used to treat neurodegenerative diseases. However, GAP‐43 is a target for the specific apoptotic protease calpain‐2, whose hyperactivation may have negative consequences for the CNS. We found that DEX stimulates GAP‐43 mRNA and protein production in the rat hippocampus. DEX administration at a dose of 8 mg/kg (once intraperitoneally) leads to an increase in GAP‐43 protein levels and calpain‐2 activation in the striatum and prefrontal cortex of rats; however, calpain‐2 protein production is increased in the striatum and decreased in the prefrontal cortex. Our data support the hypothesis that DEX can be used to enhance the production of GAP‐43 and other proteins crucial for brain function, such as tyrosine hydroxylase and calpains. This approach could potentially be employed to stimulate regenerative processes in the brain following acute injury or as a pulse therapy for chronic neurodegenerative conditions.
- 25 May 2025
- Published by Wiley in European Journal of Neuroscience
- Vol. 61 (10) , e70146
Intraperitoneal Single Injection of Dexamethasone Leads to Region‐Specific Changes in the Profile of Neuron‐Specific Proteins in the Rat Brain
This study aims to investigate the effect of dexamethasone (DEX) injection on the production of growth‐associated protein 43 (GAP‐43), the protein that promotes calpain‐2 activation. Increased levels of GAP‐43 in the central nervous system can stimulate plastic and regenerative processes in the brain, which can be used to treat neurodegenerative diseases. However, GAP‐43 is a target for the specific apoptotic protease calpain‐2, whose hyperactivation may have negative consequences for the CNS. We found that DEX stimulates GAP‐43 mRNA and protein production in the rat hippocampus. DEX administration at a dose of 8 mg/kg (once intraperitoneally) leads to an increase in GAP‐43 protein levels and calpain‐2 activation in the striatum and prefrontal cortex of rats; however, calpain‐2 protein production is increased in the striatum and decreased in the prefrontal cortex. Our data support the hypothesis that DEX can be used to enhance the production of GAP‐43 and other proteins crucial for brain function, such as tyrosine hydroxylase and calpains. This approach could potentially be employed to stimulate regenerative processes in the brain following acute injury or as a pulse therapy for chronic neurodegenerative conditions.
- Open Access
- 19 March 2025
- Published by Elsevier in Toxicology Reports
- Vol. 14, 102001
Manganese-induced damage to the serotoninergic system is associated with the development of anxiety and depression
- 19 March 2025
- Published by Elsevier in Toxicology Reports
- Vol. 14, 102001
Open AccessManganese-induced damage to the serotoninergic system is associated with the development of anxiety and depression
- Open Access
- 24 December 2024
- Published by ECO-Vector LLC in Medical academic journal
- Vol. 24 (3) , 133-138
Dexamethasone-induced changes in the expression profile of “neuroinflammatory” genes
BACKGROUND: Glucocorticoids play an important role in the development of the stress response in the organism. Synthetic glucocorticoids such as dexamethasone are widely used in medicine due to their anti-inflammatory effects. However, there is evidence that glucocorticoid-based drugs used in sufficiently high doses can induce pro-inflammatory effects by affecting predominantly the hippocampus in the central nervous system as the most plastic brain structure. It is important to note that the dose, route and timing of administration can affect the effects of glucocorticoids, and it is therefore an important biomedical task to choose the optimal parameters of glucocorticoid administration in order to achieve the most effective treatment results. AIM: The aim of our study was to investigate the effect of peripheral administration of a synthetic glucocorticoid, dexamethasone, at a dose of 8 mg/kg on the development of neuroinflammation in the rat hippocampus at different periods after administration. MATERIALS AND METHODS: Thirty-two sexually mature male Wistar rats distributed into 8 groups of 4 animals each were used in the experiment. The animals were injected with dexamethasone at a dose of 8 mg/kg and decapitated for different periods (1, 3, 9, 12, 18, 24, 48 hours — time of decapitation after administration), group К — control group with saline injection). Further, the cytokine profile expression was analyzed by real-time reverse transcription polymerase chain reaction method. RESULTS: In this study, we found an increase in the expression of proinflammatory cytokines AIF1 (IBA-1) and IL-1β after 12 and TNF-α after 24 hours after dexamethasone administration at a dose of 8 mg/kg, which may indicate a neuroinflammatory effect of dexamethasone at this dose. It should be noted that the level of NF-êB gene, a marker of inflammation, remained unchanged, possibly due to the activation of compensatory mechanisms to control inflammation or stress. CONCLUSIONS: The increase in mRNA of inflammatory markers IL-1β, TNF-α and AIF1, in the hippocampus after 12 hours after single dexamethasone administration to rats at a dose of 8 mg/kg may indicate a switch of the effect of this drug from antiinflammatory to proinflammatory, which should be taken into account when dexamethasone is used such a treatment during several diseases.
- 24 December 2024
- Published by ECO-Vector LLC in Medical academic journal
- Vol. 24 (3) , 133-138
Open AccessDexamethasone-induced changes in the expression profile of “neuroinflammatory” genes
BACKGROUND: Glucocorticoids play an important role in the development of the stress response in the organism. Synthetic glucocorticoids such as dexamethasone are widely used in medicine due to their anti-inflammatory effects. However, there is evidence that glucocorticoid-based drugs used in sufficiently high doses can induce pro-inflammatory effects by affecting predominantly the hippocampus in the central nervous system as the most plastic brain structure. It is important to note that the dose, route and timing of administration can affect the effects of glucocorticoids, and it is therefore an important biomedical task to choose the optimal parameters of glucocorticoid administration in order to achieve the most effective treatment results. AIM: The aim of our study was to investigate the effect of peripheral administration of a synthetic glucocorticoid, dexamethasone, at a dose of 8 mg/kg on the development of neuroinflammation in the rat hippocampus at different periods after administration. MATERIALS AND METHODS: Thirty-two sexually mature male Wistar rats distributed into 8 groups of 4 animals each were used in the experiment. The animals were injected with dexamethasone at a dose of 8 mg/kg and decapitated for different periods (1, 3, 9, 12, 18, 24, 48 hours — time of decapitation after administration), group К — control group with saline injection). Further, the cytokine profile expression was analyzed by real-time reverse transcription polymerase chain reaction method. RESULTS: In this study, we found an increase in the expression of proinflammatory cytokines AIF1 (IBA-1) and IL-1β after 12 and TNF-α after 24 hours after dexamethasone administration at a dose of 8 mg/kg, which may indicate a neuroinflammatory effect of dexamethasone at this dose. It should be noted that the level of NF-êB gene, a marker of inflammation, remained unchanged, possibly due to the activation of compensatory mechanisms to control inflammation or stress. CONCLUSIONS: The increase in mRNA of inflammatory markers IL-1β, TNF-α and AIF1, in the hippocampus after 12 hours after single dexamethasone administration to rats at a dose of 8 mg/kg may indicate a switch of the effect of this drug from antiinflammatory to proinflammatory, which should be taken into account when dexamethasone is used such a treatment during several diseases.
- Open Access
- 24 December 2024
- Published by ECO-Vector LLC in Medical academic journal
- Vol. 24 (3) , 110-117
Alterations in the expression of dopamine catabolism genes in DAT-KO rats with induced valproate syndrome
BACKGROUND: Autism spectrum disorder and attention deficit hyperactivity disorder are complex disorders of nervous development. Both diseases are diagnosed in childhood and are often comorbital. Rats with a knockout of the dopamine transporter gene (DAT) exhibit symptoms characteristic of attention deficit hyperactivity disorder. Prenatal treatment with valproic acid is used to model autism spectrum disorder. Dysfunction of the dopaminergic system may be one of the causes of attention deficit hyperactivity disorder and autism spectrum disorder. However the neurochemical mechanisms underlying dysfunction of the dopaminergic system and contributing to the pathogenesis of attention deficit hyperactivity disorder require further studies. AIM: Therefore, the aim of the work was to investigate the expression levels of dopamine catabolism genes in heterozygous rats with a knockout of the DAT encoding gene and induced valproate syndrome. MATERIALS AND METHODS: The work was performed on 32 rats aged 40 days (adolescence). In total, 4 groups of baby rats were formed in the study: DAT:Salt, DAT:VPA, WT:VPA and WT:Salt, where DAT/WT is the presence or absence of a genetic factor (DAT is a heterozygote for knockout of the SLC6A3 gene, WT is the wild type), VPA/Salt is the presence or absence of a toxic factor (induced valproate syndrome). RESULTS: The expression of mRNA monoamine oxidase A and monoamine oxidase B in the midbrain was reduced in the groups DAT:Sat, DAT:VPA, WT:VPA compared to the control group WT:Salt. The expression mRNA of catechol-O-methyltransferase mRNA in the midbrain of rats DAT:Salt is significantly higher than in the control group WT:Salt, however, the treatment with valproic acid leads to a decrease in catechol-O-methyltransferase expression in heterozygous rats by knocking out the SLC6A3 gene. No changes in the expression of monoamine oxidase A, monoamine oxidase B, catechol-O-methyltransferase mRNA were observed in the prefrontal cortex and striatum. CONCLUSIONS: The development of valproate syndrome and/or reduce dopamine reuptake leads to a decrease in the levels of monoamine oxidase A and monoamine oxidase B mRNA in the rat midbrain. Prenatal exposure to valproic acid led to a decrease in the level of catechol-O-methyltransferase mRNA in the midbrain of heterozygous rats by knockout of the DAT gene.
- 24 December 2024
- Published by ECO-Vector LLC in Medical academic journal
- Vol. 24 (3) , 110-117
Open AccessAlterations in the expression of dopamine catabolism genes in DAT-KO rats with induced valproate syndrome
BACKGROUND: Autism spectrum disorder and attention deficit hyperactivity disorder are complex disorders of nervous development. Both diseases are diagnosed in childhood and are often comorbital. Rats with a knockout of the dopamine transporter gene (DAT) exhibit symptoms characteristic of attention deficit hyperactivity disorder. Prenatal treatment with valproic acid is used to model autism spectrum disorder. Dysfunction of the dopaminergic system may be one of the causes of attention deficit hyperactivity disorder and autism spectrum disorder. However the neurochemical mechanisms underlying dysfunction of the dopaminergic system and contributing to the pathogenesis of attention deficit hyperactivity disorder require further studies. AIM: Therefore, the aim of the work was to investigate the expression levels of dopamine catabolism genes in heterozygous rats with a knockout of the DAT encoding gene and induced valproate syndrome. MATERIALS AND METHODS: The work was performed on 32 rats aged 40 days (adolescence). In total, 4 groups of baby rats were formed in the study: DAT:Salt, DAT:VPA, WT:VPA and WT:Salt, where DAT/WT is the presence or absence of a genetic factor (DAT is a heterozygote for knockout of the SLC6A3 gene, WT is the wild type), VPA/Salt is the presence or absence of a toxic factor (induced valproate syndrome). RESULTS: The expression of mRNA monoamine oxidase A and monoamine oxidase B in the midbrain was reduced in the groups DAT:Sat, DAT:VPA, WT:VPA compared to the control group WT:Salt. The expression mRNA of catechol-O-methyltransferase mRNA in the midbrain of rats DAT:Salt is significantly higher than in the control group WT:Salt, however, the treatment with valproic acid leads to a decrease in catechol-O-methyltransferase expression in heterozygous rats by knocking out the SLC6A3 gene. No changes in the expression of monoamine oxidase A, monoamine oxidase B, catechol-O-methyltransferase mRNA were observed in the prefrontal cortex and striatum. CONCLUSIONS: The development of valproate syndrome and/or reduce dopamine reuptake leads to a decrease in the levels of monoamine oxidase A and monoamine oxidase B mRNA in the rat midbrain. Prenatal exposure to valproic acid led to a decrease in the level of catechol-O-methyltransferase mRNA in the midbrain of heterozygous rats by knockout of the DAT gene.
- 29 October 2024
- Published by ECO-Vector LLC in Medical academic journal
- Vol. 24 (2) , 79-91
Delayed effects of antibiotic therapy in endotoxinemia
BACKGROUND: Nowadays, due to the increasing number of infectious and inflammatory diseases, the problem of the use of antibacterial drugs becomes especially important. As a result of the action of toxins, inflammatory processes can affect the central nervous system with the subsequent development of neuroinflammation. Activation of neuroinflammation leads to dysregulation of many physiological functions. These negative appearances can be observed even after a long period. It is known that doxycycline is a tetracycline-type antibiotic, which is able to penetrate the blood-brain barrier and has anti-inflammatory activity. AIM: The aim of this study was to investigate the nature of delayed physiological changes in rats against the background of administration of the antibacterial drug doxycycline in the LPS-induced model of neuroinflammation. MATERIALS AND METHODS: Four groups of Wistar rats, 10 males in each group, were used in the experiment. The first group was injected once intraperitoneally with physiological solution, the second group — with lipopolysaccharide (1 mg/kg). Animals of the third and fourth groups received intragastrically doxycycline solution (25 mg/kg) daily for two weeks. On the 15th day of the experiment, rats from the fourth group were injected with lipopolysaccharide (1 mg/kg). Body weight of animals, mass coefficients of immunocompetent organs, as well as behaviour and motor activity of rats in the “Open Field” test were evaluated at several time points. RESULTS: It was shown that systemic injection of lipopolysaccharide led to an increase in the mass coefficients of spleen, kidneys and adrenal glands compared to the group of animals receiving doxycycline beforehand. These changes were noted 48 h and 2 months after the injection of endotoxin. In the “Open Field” test, animals that were injected with doxycycline and lipopolysaccharide showed no violations of motor activity and research behavior, unlike the group that received only lipopolysaccharide. CONCLUSIONS: It can be assumed that the physiological effects of doxycycline in the lipopolysaccharide-induced model of neuroinflammation revealed at early and late terms are not limited to the antibacterial effect of the drug and are mediated by anti-inflammatory and potential neuroprotective effects on the central nervous system.
- 29 October 2024
- Published by ECO-Vector LLC in Medical academic journal
- Vol. 24 (2) , 79-91
Delayed effects of antibiotic therapy in endotoxinemia
BACKGROUND: Nowadays, due to the increasing number of infectious and inflammatory diseases, the problem of the use of antibacterial drugs becomes especially important. As a result of the action of toxins, inflammatory processes can affect the central nervous system with the subsequent development of neuroinflammation. Activation of neuroinflammation leads to dysregulation of many physiological functions. These negative appearances can be observed even after a long period. It is known that doxycycline is a tetracycline-type antibiotic, which is able to penetrate the blood-brain barrier and has anti-inflammatory activity. AIM: The aim of this study was to investigate the nature of delayed physiological changes in rats against the background of administration of the antibacterial drug doxycycline in the LPS-induced model of neuroinflammation. MATERIALS AND METHODS: Four groups of Wistar rats, 10 males in each group, were used in the experiment. The first group was injected once intraperitoneally with physiological solution, the second group — with lipopolysaccharide (1 mg/kg). Animals of the third and fourth groups received intragastrically doxycycline solution (25 mg/kg) daily for two weeks. On the 15th day of the experiment, rats from the fourth group were injected with lipopolysaccharide (1 mg/kg). Body weight of animals, mass coefficients of immunocompetent organs, as well as behaviour and motor activity of rats in the “Open Field” test were evaluated at several time points. RESULTS: It was shown that systemic injection of lipopolysaccharide led to an increase in the mass coefficients of spleen, kidneys and adrenal glands compared to the group of animals receiving doxycycline beforehand. These changes were noted 48 h and 2 months after the injection of endotoxin. In the “Open Field” test, animals that were injected with doxycycline and lipopolysaccharide showed no violations of motor activity and research behavior, unlike the group that received only lipopolysaccharide. CONCLUSIONS: It can be assumed that the physiological effects of doxycycline in the lipopolysaccharide-induced model of neuroinflammation revealed at early and late terms are not limited to the antibacterial effect of the drug and are mediated by anti-inflammatory and potential neuroprotective effects on the central nervous system.
- 17 July 2024
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 34 (9) , 1035-1044
Spatial memory impairment is associated with decreased dopamine-β-hydroxylase activity in the brains of rats exposed to manganese chloride
Chronic exposure to manganese compounds leads to accumulation of the manganese in the basal ganglia and hippocampus. High levels of manganese in these structures lead to oxidative stress, neuroinflammation, imbalance of brain neurotransmitters, and hyperactivation of calpains mediating neurotoxicity and causing motor and cognitive impairment. The purpose of this work was to study the effect of excess manganese chloride intake on rats' spatial memory and on dopamine-β-hydroxylase (DβH) activity under conditions of calpain activity suppression. Rats were divided into 3 groups of 10 animals each. Group 1 received MnCl2 (30 days, 5 mg/kg/day, intranasally), group 2 received MnCl2 (30 days, 5 mg/kg/day, intranasally) and calpain inhibitor Cast (184-210) (30 days, 5 µg/kg/day, intranasally), and group 3 received sterile saline (30 days in a volume of 20 μl, intranasally). The spatial working memory was assessed using Morris water maze test. DβH activity was determined by HPLC. We have shown that in response to excessive intake of MnCl2, there was a development of cognitive impairments in rats, which was accompanied by a decrease in DβH activity in the hippocampus. The severity of cognitive impairment was reduced by inhibiting the activity of m-calpain. The protective effect of calpain inhibitors was achieved not through an effect on DβH activity. Thus, the development of therapeutic regimens for the treatment of manganism using dopaminomimetics and/or by inhibiting calpains, must be performed taking into account the manganese-induced decrease of DβH activity and the inability to influence this process with calpain inhibitors.
- 17 July 2024
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 34 (9) , 1035-1044
Spatial memory impairment is associated with decreased dopamine-β-hydroxylase activity in the brains of rats exposed to manganese chloride
Chronic exposure to manganese compounds leads to accumulation of the manganese in the basal ganglia and hippocampus. High levels of manganese in these structures lead to oxidative stress, neuroinflammation, imbalance of brain neurotransmitters, and hyperactivation of calpains mediating neurotoxicity and causing motor and cognitive impairment. The purpose of this work was to study the effect of excess manganese chloride intake on rats' spatial memory and on dopamine-β-hydroxylase (DβH) activity under conditions of calpain activity suppression. Rats were divided into 3 groups of 10 animals each. Group 1 received MnCl2 (30 days, 5 mg/kg/day, intranasally), group 2 received MnCl2 (30 days, 5 mg/kg/day, intranasally) and calpain inhibitor Cast (184-210) (30 days, 5 µg/kg/day, intranasally), and group 3 received sterile saline (30 days in a volume of 20 μl, intranasally). The spatial working memory was assessed using Morris water maze test. DβH activity was determined by HPLC. We have shown that in response to excessive intake of MnCl2, there was a development of cognitive impairments in rats, which was accompanied by a decrease in DβH activity in the hippocampus. The severity of cognitive impairment was reduced by inhibiting the activity of m-calpain. The protective effect of calpain inhibitors was achieved not through an effect on DβH activity. Thus, the development of therapeutic regimens for the treatment of manganism using dopaminomimetics and/or by inhibiting calpains, must be performed taking into account the manganese-induced decrease of DβH activity and the inability to influence this process with calpain inhibitors.